Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 139.04 USD -0.39%
Market Cap: 40B USD
Have any thoughts about
Agilent Technologies Inc?
Write Note

Agilent Technologies Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Agilent Technologies Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Agilent Technologies Inc
NYSE:A
Non-Reccuring Items
-$74m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Non-Reccuring Items
-$231m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Non-Reccuring Items
-$222m
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
West Pharmaceutical Services Inc
NYSE:WST
Non-Reccuring Items
-$100k
CAGR 3-Years
71%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Non-Reccuring Items
-$30.7m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Non-Reccuring Items
-$94m
CAGR 3-Years
-30%
CAGR 5-Years
-6%
CAGR 10-Years
-26%
No Stocks Found

Agilent Technologies Inc
Glance View

Market Cap
40B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Agilent Technologies Inc. is a leading global innovator in life sciences, diagnostics, and applied chemical markets, embodying a commitment to advancing scientific discovery and improving healthcare outcomes. Founded in 1999 as a spin-off from Hewlett-Packard, Agilent has strategically positioned itself at the nexus of key industries where powerful analytical tools and technologies are essential. The company's robust portfolio includes sophisticated instruments, software, and services that facilitate groundbreaking research in pharmaceuticals, environmental monitoring, and food safety, making it an indispensable partner for laboratories and research institutions worldwide. With a focus on precision and efficiency, Agilent's solutions enable businesses and scientists to make informed decisions that drive progress in health and safety. Investors are drawn to Agilent not only for its impressive technological capabilities but also for its strong financial performance and a clear growth strategy rooted in innovation and customer collaboration. The company has leveraged its expertise in mass spectrometry, chromatography, and genomics to enhance its offering, tapping into rising trends in personalized medicine and biopharmaceutical development. This dedication to growth is reflected in Agilent's consistent revenue increases and healthy profit margins, underscoring its resilience in a competitive marketplace. As the world increasingly turns toward data-driven approaches in science and healthcare, Agilent stands out as a critical player, promising robust returns for investors seeking exposure to a company that is shaping the future of science and technology.

A Intrinsic Value
109.52 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Agilent Technologies Inc's Non-Reccuring Items?
Non-Reccuring Items
-74m USD

Based on the financial report for Jul 31, 2024, Agilent Technologies Inc's Non-Reccuring Items amounts to -74m USD.

Back to Top